Elekta AB ser. B (EKTABs)

Currency in SEK
49.37
0.00(0.00%)
Closed·
EKTABs Scorecard
Full Analysis
Net income is expected to grow this year
High dividend Yield
EKTABs is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
49.3749.37
52 wk Range
47.3372.45
Key Statistics
Bid/Ask
64.30 / 61.30
Prev. Close
49.37
Open
49.37
Day's Range
49.37-49.37
52 wk Range
47.33-72.45
Volume
-
Average Volume (3m)
7.88K
1-Year Change
-22.62%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EKTABs Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield

Elekta AB ser. B News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Elekta AB ser. B Company Profile

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear accelerator and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo that delivers offline and online adaptive radiation therapy; Elekta Versa HD, a brain metastases solution; Elekta Harmony; and Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs, as well as quality assurance, and treatment and motion management solutions. It also provides stereotactic radiosurgery products, such as Elekta Esprit, a gamma knife system; and Leksell GammaPlan, a treatment planning and management software, as well as Elekta ONE, an oncology software suite. In addition, the company offers brachytherapy products, including Elekta Studio, an image-guided brachytherapy solution; ImagingRing for dynamic imaging; Oncentra Brachy, a smart tool that facilitates repetitive tasks; Elekta Xoft Axxent and electronic brachytherapy systems; Elekta Geneva, an applicator for cervical cancer patients; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Venezia applicator that enables the oncologist to treat locally advanced cervical cancer. Further, it provides Leksell Vantage Stereotactic System, a neurosurgery product; Elekta Kaiku for personalized cancer care; and veterinary radiation therapy solutions. Additionally, the company offers Elekta Care support services; Elekta Care 360, which provides a range of clinical and professional services; Elekta Care Learning that offers in-person and digital training courses on radiotherapy; Elekta Care Community, a self-help center; Elekta Partner Community, an online self-service portal; and Elekta Intellimax for predictive maintenance. Elekta AB (publ) was incorporated in 1972 and is headquartered in Stockholm, Sweden.

Employees
4487
Market
Sweden

Compare EKTABs to Peers and Sector

Metrics to compare
EKTABs
Peers
Sector
Relationship
P/E Ratio
76.9x28.8x−0.5x
PEG Ratio
−0.940.790.00
Price/Book
2.1x2.7x2.6x
Price / LTM Sales
1.0x2.6x3.3x
Upside (Analyst Target)
-33.0%43.3%
Fair Value Upside
Unlock14.7%6.9%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.62%
Dividend Yield
4.90%
Industry Median 1.96%
Annualised payout
2.40
Paid unevenly
5-Years Growth
+21.67%
Growth Streak

Earnings

Latest Release
May 28, 2025
EPS / Forecast
1.11 / 1.48
Revenue / Forecast
5.16B / 5.31B
EPS Revisions
Last 90 days

EKTABs Income Statement

People Also Watch

13.205
REP
-0.97%
73.3400
PRY
-0.78%
33.4800
GASI
+0.45%
8.020
STLAM
-0.82%
5.326
NEXII
-1.19%

FAQ

What Stock Exchange Does Elekta B Trade On?

Elekta B is listed and trades on the BATS Europe stock exchange.

What Is the Stock Symbol for Elekta B?

The stock symbol for Elekta B is "EKTABs."

What Is the Elekta B Market Cap?

As of today, Elekta B market cap is 18.86B.

What Is Elekta B's Earnings Per Share (TTM)?

The Elekta B EPS (TTM) is 0.62.

When Is the Next Elekta B Earnings Date?

Elekta B will release its next earnings report on 27 Aug 2025.

From a Technical Analysis Perspective, Is EKTABs a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Elekta B Stock Split?

Elekta B has split 2 times.

How Many Employees Does Elekta B Have?

Elekta B has 4487 employees.

What is the current trading status of Elekta B (EKTABs)?

As of 11 Aug 2025, Elekta B (EKTABs) is trading at a price of 49.37, with a previous close of 49.37. The stock has fluctuated within a day range of 49.37 to 49.37, while its 52-week range spans from 47.33 to 72.45.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.